Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn

被引:26
作者
Modhave, Dattatray T. [1 ]
Handa, Tarun [1 ]
Shah, Ravi P. [1 ]
Singh, Saranjit [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER, Dept Pharmaceut Anal, Sect 67, Sas Nagar 160062, Punjab, India
关键词
Lornoxicam; Stress testing; LC-MS; Characterization; Degradation mechanism; PRODUCTS; IDENTIFICATION; BEHAVIOR; STRATEGY;
D O I
10.1016/j.jpba.2011.06.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Lornoxicam was subjected to forced degradation studies under hydrolytic (acidic, basic and neutral), oxidative, photolytic and thermal stress conditions, as defined under ICH guideline Q1A (R2). The drug degraded significantly in hydrolytic, oxidative and photoneutral conditions, leading to the formation of eight degradation products in total. It was stable on exposure to light and dry heat in the solid state. The stressed samples in which degradation was observed were mixed together and used to develop a stability-indicating HPLC method wherein degradation products were separated from the drug and also from each other. To characterize the degradation products, a complete mass fragmentation pathway of the drug was first established with the help of MS/TOF, MSn and H/D exchange mass studies. The same was followed by LC-MS/TOF and on-line H/D exchange experiments on the degradation products. The degradation pathway of the drug was outlined, justified by the mechanisms of formation of the degradation products. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:538 / 545
页数:8
相关论文
共 19 条
  • [1] [Anonymous], 1996, INT C HARM
  • [2] Bansal G, 2008, J AOAC INT, V91, P709
  • [3] Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method
    Bhardwaj, Sunny Piyush
    Singh, Saranjit
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (01) : 113 - 120
  • [4] Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation
    Kumar, Vijay
    Shah, Ravi P.
    Malik, Satish
    Singh, Saranjit
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (04) : 880 - 888
  • [5] On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities
    Liu, David Q.
    Wu, Lianming
    Sun, Mingjiang
    MacGregor, Paul A.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 44 (02) : 320 - 329
  • [6] MARCH J, 2005, ADV ORG CHEM, P383
  • [7] Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug
    Mehta, Surbhi
    Shah, Ravi P.
    Singh, Saranjit
    [J]. DRUG TESTING AND ANALYSIS, 2010, 2 (1-2) : 82 - 90
  • [8] LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil
    Mehta, Surbhi
    Shah, Ravi P.
    Priyadarshi, Rajkamal
    Singh, Saranjit
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 52 (03) : 345 - 354
  • [9] Parker K. L., 2006, GOODMAN GILMANS PHAR, P700
  • [10] Stability-Indicating LC Method for Analysis of Lornoxicam in the Dosage Form
    Patil, Kiran R.
    Rane, Vipul P.
    Sangshetti, Jaiprakash N.
    Shinde, Devanand B.
    [J]. CHROMATOGRAPHIA, 2009, 69 (9-10) : 1001 - 1005